NIAID's HIV/AIDS Research Program
Although progress has been made in the global fight against HIV/AIDS, the epidemic continues to devastate the United States and the international community with an average of 50,000 new HIV infections each year in the United States and an estimated 34 million people living with HIV worldwide. As the leading U.S. government institute for HIV/AIDS research, NIAID is committed to conducting the research necessary to successfully end the fight against HIV/AIDS.
Through laboratories and clinics on the National Institutes of Health campus in Bethesda, Maryland, and a vast network of supported research at universities, medical centers and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection including a preventive vaccine, develop new and more effective treatments for people infected with HIV, and hopefully, find a cure.
Learn more about NIAID's role in HIV/AIDS research.
